Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Apatinib|DRUG: capecitabine
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences